Replies to post #72643 on Ayala Pharmaceuticals Inc (ADXS)

[zzaatt]

It has been really painful being on the wrong side.

True, but the way I see it, if the company
makes a solid recovery (I'm betting on it!) then all the pain
will be forgotten. I say this as an Ariad investor who went thru
a couple of years of depressed pps, then recovered (for me
a very reasonable ROI). I thought at the time that the clinical
results would be decisive, and patient benefit was quite substantial.

The equivalent in ADXS would/should have greater impact since
we have a platform with applicability in a multitude of cancers.
We need to keep extending the runway and reassuring investors
that the company has the means to get there. I hope that the new CEO
can achieve that soon. If that happens then it's just a matter of Dr.Petit
proving that his belief is justified (quote from him):

"we believe that our patient specific NEO and cancer type specific HOT
product candidate has the potential to become a cornerstone of immunotherapy. "